Sculptor Capital’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Sculptor Capital’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-70,000	Closed	-$62K	–	1234
2022 Q1	$62K	Sell	70,000 -541,655	-89%	-$603K	﹤0.01%	1046
2021 Q4	$1.36M	Buy	611,655 +445,161	+267%	+$1.44M	0.01%	641
2021 Q3	$565K	Buy	+166,494	New	+$593K	﹤0.01%	637

Other funds holding DNA.WS

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return